Iterum Therapeutics plc — All Filings
507 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B1
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-24-120154 | Nov 1, 2024 | Oct 28, 2024 |
| 424B5 | 424B5 | 0001193125-24-246970 | Oct 30, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-244547 | Oct 28, 2024 | — |
| 8-K | 8-K | 0000950170-24-117270 | Oct 25, 2024 | — |
| 8-K | 8-K | 0000950170-24-114467 | Oct 15, 2024 | Oct 9, 2024 |
| 424B5 | 424B5 | 0001193125-24-236708 | Oct 11, 2024 | — |
| 8-K | 8-K | 0000950170-24-113413 | Oct 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-112977 | Oct 4, 2024 | Oct 1, 2024 |
| DEFA14A | DEFA14A | 0000950170-24-110169 | Sep 30, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-110374 | Sep 30, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-108901 | Sep 24, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-108903 | Sep 24, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-108613 | Sep 23, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-105561 | Sep 11, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-104537 | Sep 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-096649 | Aug 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-096653 | Aug 14, 2024 | Jun 30, 2024 |
| DEF 14A | DEF 14A | 0000950170-24-097032 | Aug 14, 2024 | Sep 9, 2024 |
| EFFECT | — | 9999999995-24-002518 | Aug 13, 2024 | — |
| 4 | 4 | 0000950170-24-095096 | Aug 12, 2024 | Aug 6, 2024 |
| 4 | 4 | 0000950170-24-095094 | Aug 12, 2024 | Aug 6, 2024 |
| 4 | 4 | 0000950170-24-095095 | Aug 12, 2024 | Aug 6, 2024 |
| POS AM | POS AM | 0001193125-24-197988 | Aug 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-092011 | Aug 6, 2024 | — |
| PRE 14A | PRE 14A | 0000950170-24-090020 | Aug 2, 2024 | — |
| 8-K | 8-K | 0000950170-24-085057 | Jul 22, 2024 | — |
| EFFECT | — | 9999999995-24-002205 | Jul 19, 2024 | — |
| 424B3 | 424B3 | 0001193125-24-181716 | Jul 19, 2024 | — |
| CORRESP | — | 0001193125-24-180395 | Jul 17, 2024 | — |
| S-1/A | S-1/A | 0001193125-24-180379 | Jul 17, 2024 | — |
| S-1/A | S-1/A | 0001193125-24-169204 | Jun 26, 2024 | — |
| 8-K | 8-K | 0000950170-24-077963 | Jun 26, 2024 | — |
| 8-K | 8-K | 0000950170-24-075885 | Jun 21, 2024 | Jun 19, 2024 |
| UPLOAD | — | 0000000000-24-006693 | Jun 11, 2024 | — |
| S-1 | S-1 | 0001193125-24-157345 | Jun 7, 2024 | — |
| 8-K | 8-K | 0000950170-24-066932 | May 31, 2024 | May 29, 2024 |
| 10-Q | 10-Q | 0000950170-24-058200 | May 13, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0000950170-24-058190 | May 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-057831 | May 10, 2024 | — |
| 8-K | 8-K | 0000950170-24-049928 | Apr 29, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-048646 | Apr 26, 2024 | Jun 19, 2024 |
| DEFA14A | DEFA14A | 0000950170-24-048651 | Apr 26, 2024 | — |
| ARS | ARS | 0000950170-24-048655 | Apr 26, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0000950170-24-042288 | Apr 5, 2024 | Apr 3, 2024 |
| 8-K | 8-K | 0000950170-24-038414 | Mar 29, 2024 | Mar 28, 2024 |
| 10-K | 10-K | 0000950170-24-037615 | Mar 28, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0000950170-24-026878 | Mar 6, 2024 | — |
| SC 13G | ITERUM THERAPEUTICS PLC | 0000902664-24-000843 | Jan 31, 2024 | — |
| 8-K | 8-K | 0000950170-24-008530 | Jan 30, 2024 | — |
| 8-K | 8-K | 0000950170-24-008937 | Jan 30, 2024 | — |